2,000,000 Shares of ADAMIS PHARMACEUTICALS CORPORATION Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • January 9th, 2015 • Adamis Pharmaceuticals Corp • Pharmaceutical preparations • New York
Adamis Pharmaceuticals Corporation, a Delaware corporation (collectively with its subsidiaries, the “Company”), proposes, subject to the terms and conditions contained herein, to sell to you and the other underwriters named on Schedule I to this Agreement (the “Underwriters”), for whom you are acting as Representative (the “Representative”), an aggregate of 2,000,000 shares (the “Firm Shares”) of the Company’s common stock, par value $0.0001 per share (the “Common Stock”). All of the Firm Shares are to be issued and sold by the Company. The respective amounts of the Firm Shares to be purchased by each of the several underwriters are set forth opposite their names on Schedule I hereto (the “Underwriters”). In addition, but subject to the limitations under Instruction B.6 of the Form S-3, the Company proposes to grant to the Underwriters an option to purchase up to an additional 300,000 shares of Common Stock from the Company for the purpose of covering over-allotments in connection with
